Skip to main content

Table 3 Overall test of coincidence of regression lines

From: Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis

Patient ID

Slope pre-IV

Slope post-IV

p-value

SEQ1

7.55

0.96

< 0.001

SEQ2

7.55

0.72

< 0.001

SEQ3

2.32

−0.97

< 0.001

SEQ4

3.60

−0.75

0.015

SEQ5

1.00

1.39

0.616

SEQ6

0

0.18

0.236

SEQ7

N/A

4.19

n/a

SEQ8

N/A

0.37

n/a

SEQ9

N/A

1.29

n/a

IV1

N/A

1

n/a

  1. Slopes were calculated independently for pre-intravenous (pre-IV) infusions and post-IV infusions, and when data was available for both, p-values were generated
  2. N/A data not available, n/a not applicable
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172